PRISM Mid-Day Movers: Dilution and Defense Contract Fuels Big Swings in Healthcare and NextGen Tech

Stock Information for NanoVibronix Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About NanoVibronix Inc.

Immuron - FY25 global sales exceed projection, up 49% on prior year
Immuron Letter to Shareholders: Projects Update
Immuron Travelan® highest sales in history
Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS)
Presenting on the Emerging Growth Conference 79 Day 1 on February 18 Register Now
Immuron Travelan® continued strong sales growth
Immuron Announces New Research Collaboration targeting Antimicrobial Resistance
Immuron Announces Travelan® Clinical Trial Update

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.